Indic Regen Pharmaceuticals Private Limited
About Indic Regen Pharmaceuticals Private Limited
Data last updated:
Indic Regen Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 March 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2022PTC161655.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Alok Kumar Pandey and Amit Kumar Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No.103 Presidency Tower Omega Green Park Township Chinhat, Lucknow, Uttar Pradesh, India – 226028.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.03 Lakh. For the same year it recorded a net loss of ₹1.73 Lakh (net margin -57.1%) and EBITDA of -₹1.73 Lakh (EBITDA margin -57%).
Company details
Contact details
Indic Regen Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered AddressFlat No.103 Presidency Tower Omega Green Park Township Chinhat, Lucknow, Uttar Pradesh, India – 226028
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indic Regen Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Indic Regen Pharmaceuticals Private Limited, buy the company report.
Financials of Indic Regen Pharmaceuticals Private Limited
FY 2025 filings availableIndic Regen Pharmaceuticals Private Limited reported revenue of ₹3.03 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.73 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.73 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -57% | |||
| Net Profit Margin | -57.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Indic Regen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indic Regen Pharmaceuticals Private Limited
Indic Regen Pharmaceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alok Kumar Pandey | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
| Amit Kumar Pandey Also directs: Bmu Infra Private Limited | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
| Saurabh Gupta | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
| Ashutosh Dwivedi | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
| Pushpa Mishra | Director | 07 Jul 2025 | 1 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Indic Regen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indic Regen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Indic Regen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Indic Regen Pharmaceuticals Private Limited has 7 board changes on record since 2022: 6 appointments and 1 cessation. The latest: Pushpa Mishra was appointed as Director on 07 Jul 2025.
Frequently asked questions
Indic Regen Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 March 2022 (4+ years old) and is registered under CIN U24290UP2022PTC161655.
Indic Regen Pharmaceuticals has 5 current directors:
- Alok Kumar Pandey - Director
- Amit Kumar Pandey - Director
- Saurabh Gupta - Director
- Ashutosh Dwivedi - Director
- Pushpa Mishra - Director
The latest financial statements of Indic Regen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Indic Regen Pharmaceuticals is U24290UP2022PTC161655. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indic Regen Pharmaceuticals was incorporated on 31 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Pushpa Mishra was appointed as Director on 07 Jul 2025. Afroz Sher Khan ceased to be Director on 06 Jul 2025. Afroz Sher Khan was appointed as Director on 10 Mar 2025. Indic Regen Pharmaceuticals has 7 board changes on record in total.
The registered office of Indic Regen Pharmaceuticals is at Flat No.103 Presidency Tower Omega Green Park Township Chinhat, Lucknow, Uttar Pradesh, India – 226028.
Indic Regen Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Indic Regen Pharmaceuticals can be reached at its registered office: Flat No.103 Presidency Tower Omega Green Park Township Chinhat, Lucknow, Uttar Pradesh, India – 226028.
Indic Regen Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
